Suchergebnisse - "Hegele, Vanessa"

PubPharm (12)

1

Correction : Effects of Tranexamic Acid in Patients with Subarachnoid Hemorrhage in Brazil: A Prospective Observational Study with Propensity Score Analysis

enthalten in: Neurocritical care | 2023

von Rynkowski, C. | Hegele, V. | Soares, P. | +10

ErratumFor: Neurocrit Care. 2023 Aug;39(1):191-197. - PMID 37131089

2

Effects of Tranexamic Acid in Patients with Subarachnoid Hemorrhage in Brazil : A Prospective Observational Study with Propensity Score Analysis

enthalten in: Neurocritical care | 2023

von Rynkowski, C. | Hegele, V. | Soares, P. | +10

ErratumIn: Neurocrit Care. 2023 Dec;39(3):754. - PMID 37821722

3

Effects of Tranexamic Acid in Patients with Subarachnoid Hemorrhage in Brazil: A Prospective Observational Study with Propensity Score Analysis

enthalten in: Neurocritical care | 2023

von Rynkowski, C. | Hegele, V. | Soares, P. | +10

4

Effects of Tranexamic Acid in Patients with Subarachnoid Hemorrhage in Brazil: A Prospective Observational Study with Propensity Score Analysis

enthalten in: Neurocritical care | 2023

von Rynkowski, C. | Hegele, V. | Soares, P. | +10

5

Follow-up of patients receiving rituximab for diffuse large B cell lymphoma : an overview of systematic reviews

enthalten in: Annals of hematology | 2013

von Lindenmeyer, L. | Hegele, V. | Caregnato, J. | +3

6

Pharmaceutical follow-up for patients on rituximab therapy for non-Hodgkin lymphoma : what is the evidence?

enthalten in: International journal of clinical pharmacy | 2013

von Hegele, V. | Stoll, P. | Wüst, D. | +4

7

Follow-up of patients receiving rituximab for diffuse large B cell lymphoma: an overview of systematic reviews

enthalten in: Annals of hematology | 2013

von Lindenmeyer, L. | Hegele, V. | Caregnato, J. | +3

8

Follow-up of patients receiving rituximab for diffuse large B cell lymphoma: an overview of systematic reviews

enthalten in: Annals of hematology | 2013

von Lindenmeyer, L. | Hegele, V. | Caregnato, J. | +3

9

Follow-up of patients receiving rituximab for diffuse large B cell lymphoma: an overview of systematic reviews

enthalten in: Annals of hematology | 2013

von Lindenmeyer, L. | Hegele, V. | Caregnato, J. | +3

10

Pharmaceutical follow-up for patients on rituximab therapy for non-Hodgkin lymphoma: what is the evidence?

enthalten in: International journal of clinical pharmacy | 2013

von Hegele, V. | Stoll, P. | Wüst, D. | +4